Renaissance Technologies (RenTech)'s XGN Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 59,382 shares of Exagen Inc. (XGN) worth $482,776, representing 0.00% of the portfolio. First purchased in 2023-Q4, this medium-term investment has been held for 12 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained a strategic position in XGN, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2025, adding 138,000 shares. Largest reduction occurred in Q2 2026, reducing 163,672 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Exagen (XGN) Holding Value Over Time
Track share changes against reported price movement
Quarterly Exagen (XGN) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2026 | +19,782 | Add 49.95% | 59,382 | $8.13 |
| Q2 2026 | -163,672 | Reduce 80.52% | 39,600 | $4.65 |
| Q1 2026 | +65,272 | Add 47.30% | 203,272 | $3.00 |
| Q4 2025 | +138,000 | New Buy | 138,000 | $6.08 |
| Q3 2025 | -21,000 | Sold Out | 0 | $0.00 |
| Q2 2025 | -115,800 | Reduce 84.65% | 21,000 | $6.98 |
| Q1 2025 | -18,736 | Reduce 12.05% | 136,800 | $3.59 |
| Q4 2024 | -20,064 | Reduce 11.43% | 155,536 | $4.10 |
| Q3 2024 | +81,366 | Add 86.34% | 175,600 | $3.09 |
| Q2 2024 | +45,476 | Add 93.27% | 94,234 | $1.82 |
| Q1 2024 | +3,270 | Add 7.19% | 48,758 | $1.60 |
| Q4 2023 | +45,488 | New Buy | 45,488 | $2.00 |
Renaissance Technologies (RenTech)'s Exagen Investment FAQs
Renaissance Technologies (RenTech) first purchased Exagen Inc. (XGN) in Q4 2023, acquiring 45,488 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Exagen Inc. (XGN) for 12 quarters since Q4 2023.
Renaissance Technologies (RenTech)'s largest addition to Exagen Inc. (XGN) was in Q4 2025, adding 138,000 shares worth $839,040.
According to the latest 13F filing for Q3 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 59,382 shares of Exagen Inc. (XGN), valued at approximately $482,776.
As of the Q3 2026 filing, Exagen Inc. (XGN) represents approximately 0.00% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Exagen Inc. (XGN) was 203,272 shares, as reported at the end of Q1 2026.